Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—
2.19 CNY
1.95 B CNY
12.28 B CNY
350.30 M
About LIVZON PHARMACEUTI
Sector
Headquarters
Zhuhai
Founded
1992
Website
ISIN
CNE0000002Y8
FIGI
BBG000BZGSF4
Livzon Pharmaceutical Group, Inc. engages in the research and development, production, and distribution of pharmaceutical products. It offers drug preparation products, bulk medicines and intermediates, and diagnostic reagents and equipment. The company was founded on March 1, 1992, and is headquartered in Zhuhai, China.
An aggregate view of professional's ratings.
Displays a symbol's price movements over previous years to identify recurring trends.
Frequently Asked Questions
The current price of 000513 is 38.19 CNY — it has decreased by −0.73% in the past 24 hours. Watch LIVZON PHARMACEUTI stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on SZSE exchange LIVZON PHARMACEUTI stocks are traded under the ticker 000513.
000513 stock has risen by 3.95% compared to the previous week, the month change is a −6.37% fall, over the last year LIVZON PHARMACEUTI has showed a 9.24% increase.
We've gathered analysts' opinions on LIVZON PHARMACEUTI future price: according to them, 000513 price has a max estimate of 46.50 CNY and a min estimate of 43.96 CNY. Watch 000513 chart and read a more detailed LIVZON PHARMACEUTI stock forecast: see what analysts think of LIVZON PHARMACEUTI and suggest that you do with its stocks.
000513 reached its all-time high on Aug 6, 2020 with the price of 62.20 CNY, and its all-time low was 1.37 CNY and was reached on Dec 5, 2005. View more price dynamics on 000513 chart.
See other stocks reaching their highest and lowest prices.
See other stocks reaching their highest and lowest prices.
000513 stock is 2.05% volatile and has beta coefficient of 0.66. Track LIVZON PHARMACEUTI stock price on the chart and check out the list of the most volatile stocks — is LIVZON PHARMACEUTI there?
Today LIVZON PHARMACEUTI has the market capitalization of 35.36 B, it has decreased by −1.98% over the last week.
Yes, you can track LIVZON PHARMACEUTI financials in yearly and quarterly reports right on TradingView.
LIVZON PHARMACEUTI is going to release the next earnings report on Mar 26, 2025. Keep track of upcoming events with our Earnings Calendar.
000513 earnings for the last quarter are 0.54 CNY per share, whereas the estimation was 0.57 CNY resulting in a −5.26% surprise. The estimated earnings for the next quarter are 0.40 CNY per share. See more details about LIVZON PHARMACEUTI earnings.
LIVZON PHARMACEUTI revenue for the last quarter amounts to 2.80 B CNY, despite the estimated figure of 3.25 B CNY. In the next quarter, revenue is expected to reach 2.77 B CNY.
000513 net income for the last quarter is 501.76 M CNY, while the quarter before that showed 563.15 M CNY of net income which accounts for −10.90% change. Track more LIVZON PHARMACEUTI financial stats to get the full picture.
Yes, 000513 dividends are paid annually. The last dividend per share was 1.35 CNY. As of today, Dividend Yield (TTM)% is 3.51%. Tracking LIVZON PHARMACEUTI dividends might help you take more informed decisions.
LIVZON PHARMACEUTI dividend yield was 3.83% in 2023, and payout ratio reached 63.78%. The year before the numbers were 4.62% and 73.43% correspondingly. See high-dividend stocks and find more opportunities for your portfolio.
As of Nov 9, 2024, the company has 8.93 K employees. See our rating of the largest employees — is LIVZON PHARMACEUTI on this list?
Like other stocks, 000513 shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade LIVZON PHARMACEUTI stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So LIVZON PHARMACEUTI technincal analysis shows the buy rating today, and its 1 week rating is strong buy. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating LIVZON PHARMACEUTI stock shows the strong buy signal. See more of LIVZON PHARMACEUTI technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.